MV

MGC Venture Partners

North America, Tennessee, United States, Nashville

Description

MGC Venture Partners is a venture capital firm that specializes in life sciences and innovative technology.

Investor Profile

MGC Venture Partners has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MGC Venture Partners frequently co-invest with?

Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 1
BioBrit
North America, California, United States, La Jolla
Co-Investments: 1
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 1
IV
North America, California, United States, San Francisco
Co-Investments: 1
SH
North America, Michigan, United States, Grand Rapids
Co-Investments: 1
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 1
DEFTA Partners
North America, California, United States, San Francisco
Co-Investments: 1
Syno Capital
North America, New York, United States, New York
Co-Investments: 1
KF
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1

What are some of recent deals done by MGC Venture Partners?

Castle Biosciences

Friendswood, Texas, United States

Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownJun 11, 2018
Amount Raised: $5,058,036
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownJun 27, 2017
Amount Raised: $20,000,000

Find More Investors Like MGC Venture Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

MGC Venture Partners | Pipeseed